Gopten

Gopten is a prescription medication that contains the active ingredient trandolapril, an angiotensin‑converting enzyme (ACE) inhibitor. It is supplied as oral tablets (strength not specified) and is marketed in the European Union. Trandolapril works by blocking the conversion of angiotensin I to angiotensin II, which helps to lower blood pressure and reduce the workload on the heart. The drug belongs to the class of antihypertensives and is used medical supervision.

Gopten (trandolapril) is indicated for the management of several cardiovascular conditions.

- Hypertension (high blood pressure) - Heart failure, particularly with reduced ejection fraction - Post‑myocardial infarction remodeling to improve outcomes - Adjunct therapy in diabetic patients with nephropathy (off‑label) - Prevention of progression of chronic kidney disease related to hypertension

Side effects reported with trandolapril vary in frequency and severity.

Common: - Persistent dry cough - Dizziness or light‑headedness - Headache - Fatigue or weakness - Mild hypotension, especially after the first dose - Elevated serum creatinine

Serious: - Angioedema (swelling of face, lips, tongue, or throat) - Severe hypotension leading to syncope - Acute renal failure or significant rise in serum creatinine - Hyperkalemia (high potassium levels) - Neutropenia or agranulocytosis - Hepatic dysfunction (rare)

Before starting Gopten, certain precautions should be considered.

- Pregnancy category D: avoid use during pregnancy due to fetal risk - Monitor renal function and electrolytes, especially potassium - Use cautiously in patients with hepatic impairment - Adjust dose in patients with severe renal insufficiency - Assess for a history of angioedema or hypersensitivity to ACE inhibitors - Elderly patients may be more susceptible to hypotension and renal effects - Regular blood pressure monitoring is essential after initiation

Trandolapril may interact with several other medicines.

Avoid: - Aliskiren in patients with diabetes or renal impairment - Potassium‑sparing diuretics or potassium supplements (risk of hyperkalemia) - Lithium (increased lithium levels) - Other ACE inhibitors or ARBs (dual blockade) - NSAIDs (may reduce antihypertensive effect and affect renal function)

Use with caution: - Thiazide or loop diuretics (risk of excessive blood pressure drop) - Beta‑blockers (additive hypotensive effect) - Rifampin or other enzyme inducers (may lower trandolapril levels) - Anticoagulants (monitor for bleeding if renal function changes) - Antidiabetic agents (monitor glucose as blood pressure changes can affect control)